LEADER 03210nam  22005415  450 
001 9910349449903321
005 20200705192731.0
010   $a3-030-21859-7
024 7 $a10.1007/978-3-030-21859-1
035   $a(CKB)4100000008959065
035   $a(MiAaPQ)EBC5849817
035   $a(DE-He213)978-3-030-21859-1
035   $a(PPN)260303135
035   $a(EXLCZ)994100000008959065
100   $a20190810d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aInfections in Neutropenic Cancer Patients /$fedited by Ana Paula Velez, Jorge Lamarche, John N. Greene
205   $a1st ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (187 pages)
311   $a3-030-21858-9 
327   $aCentral Nervous System Infections in Neutropenic Cancer Patients -- Head and Neck Infections.-Respiratory Infections -- Gastrointestinal and Genitourinary Infections -- Skin Infections.-Bacteremia in Neutropenic Patients -- Fungal Infections -- Neutropenic Fever -- Antifungal Medications in Neutropenia -- Antimicrobial Prophylaxis -- Antimicrobial Stewardship in Immunocompromised Host -- Index.
330   $aAs bone marrow transplant treatments and chemotherapy develop, the population of neutropenic cancer patients is on the rise. These developments are allowing patients to live longer, but in recent years, they have also led to an increase in previously rare infections and syndromes, whose management is unfamiliar to the average healthcare professional. Infections in Neutropenic Cancer Patients is a crucial resource for medical students, residents, practitioners, health professionals, and researchers. It details the clinical presentation, diagnoses, and management of an array of common infections and syndromes specific to neutropenic cancer patients, including real scenarios accompanied by color photos and radiographic results. Chapters include step-by-step tutorials, access to clinical answers on diagnosis and treatment, and a tabulated summary of the key points.
606   $aCancer$xResearch
606   $aInfectious diseases
606   $aImmunoglobulins
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096
606   $aAntibodies$3https://scigraph.springernature.com/ontologies/product-market-codes/B14010
615  0$aCancer$xResearch.
615  0$aInfectious diseases.
615  0$aImmunoglobulins.
615 14$aCancer Research.
615 24$aInfectious Diseases.
615 24$aAntibodies.
676   $a616.994
676   $a616.9
702   $aVelez$b Ana Paula$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aLamarche$b Jorge$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aGreene$b John N$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910349449903321
996   $aInfections in Neutropenic Cancer Patients$91994006
997   $aUNINA